Inactivation gating and 4-AP sensitivity in human brain Kv1.4 potassium channel

Brain Research

Volumn 831, Issue 1-2, 1999, Pages 43-54

  Judge, Susan I V ^a   Monteiro, Mervyn J ^a,c   Yeh, Jay Z ^d   Bever, Christopher T ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

4 Aminopyridine; Fast inactivation gate; Kv1.4 potassium channel; L4 heptad leucine; Mutagenesis; N terminus deletion

Indexed keywords

4 AMINOPYRIDINE; POTASSIUM CHANNEL;

AMINO TERMINAL SEQUENCE; ARTICLE; CHANNEL GATING; DEMYELINATION; GENE DELETION; HUMAN; HUMAN TISSUE; MEMBRANE CONDUCTANCE; MEMBRANE POTENTIAL; MUTAGENESIS; PERIPHERAL NERVE; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; SPINAL CORD INJURY;

4-AMINOPYRIDINE; AMINO ACID SUBSTITUTION; BRAIN; HUMANS; ION CHANNEL GATING; KV1.4 POTASSIUM CHANNEL; LEUCINE; MEMBRANE POTENTIALS; MUTATION; PATCH-CLAMP TECHNIQUES; PHENYLALANINE; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 0033549275     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01391-8     Document Type: Article

References (58)

1. + channel, Neuron 7 (1991) 471-483.
2. C.T. Bever, D. Young, P.M. Anderson, A. Krumholz, K. Conway, J. Leslie, N. Eddington, K.I. Plaisance, H.S. Panitch, S. Dhib-Jalbut, M.J. Fossler, J. Devane, K.P. Johnson, The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized placebo-controlled, double-blind, concentration-controlled crossover trial, Neurology 44 (1994) 1054-1059.
3. A.R. Blight, Effect of 4-AP on conduction block in chronic spinal cord injury, Brain Res. Bull. 22 (1989) 47-52.
4. A.R. Blight, J.P. Toombs, M.S. Bauer, W.R. Widmer, The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial, J. Neurotrauma 8 (1991) 103-119.
5. H. Bostock, T.A. Sears, R.M. Sherratt, The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated nerve fibers, J. Physiol. 313 (1981) 301-315.
6. K.G. Chandy, C.B. Williams, R.H. Spencer, B.A. Aguilar, S. Ghanshani, B.L. Tempel, G.A. Gutman, A family of three mouse potassium channel genes with intronless coding regions, Science 247 (1990) 973-975.
7. D. Choquet, H. Korn, Mechanism of 4-aminopyridine action on voltage-gated potassium channels in lymphocytes, J. Gen. Physiol. 99 (1992) 217-240.
8. F.A. Davis, D. Stefoski, C.L. Schauf, Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis, Ann. Neurol. 27 (1990) 186-192.
9. R. Graham, A.J. van der Eb, A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology 52 (1973) 456-467.
10. O.P. Hammil, A. Marty, E. Neher, B. Sakmann, F.J. Sigworth, Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches, Pflüg. Archiv. 391 (1981) 85-100.
11. R.R. Hansebout, A.R. Blight, S. Fawsett, K. Reddy, 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients, J. Neurotrauma 10 (1993) 1-18.
12. K.C. Hayes, 4-Aminopyridine and spinal cord injury: a review, Restor. Neurol. Neurosci. 6 (1994) 259-270.
13. K.C. Hayes, A.R. Blight, P.J. Potter, R.D. Allatt, J.T.C. Hsieh, D.L. Wolfe, S. Lam, J.T. Hamilton, Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury, Paraplegia 31 (1993) 216-224.
14. K.C. Hayes, P.J. Potter, D.L. Wolfe, J.T.C. Hsieh, G.A. Delaney, A.R. Blight, 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury, J. Neurotrauma 11 (1994) 433-446.
15. B. Hille (Ed.), Ionic Channels in Excitable Membranes, 2nd edn., Sinauer, Sunderland, MA, 1993.
16. T. Hoshi, W.N. Zagotta, R.W. Aldrich, Biophysical and molecular mechanisms of Shaker potassium channel inactivation, Science 250 (1990) 533-538.
17. + channel inactivation gating, in: Y. Pichon (Ed.), Comparative Molecular Neurobiology, Birchaüser Verlag, Basel, Switzerland, 1993, pp. 338-351.
18. + channel, Nature 353 (1991) 86-90.
19. S. Janicki, M.J. Monteiro, Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation, J. Cell Biol. 139 (1997) 485-495.
20. R.E. Jones, J.R. Heron, D.H. Foster, R.S. Snelgar, R.J. Mason, Effects of 4-aminopyridine in patients with multiple sclerosis, J. Neurol. Sci. 60 (1983) 353-362.
21. G.E. Kirsch, J.A. Drewe, Gating-dependent mechanism of 4-aminopyridine block of two related potassium channels, J. Gen. Physiol. 102 (1993) 797-816.
22. G.E. Kirsch, T. Narahashi, Site of action and active form of aminopyridines in squid axon membranes, J. Pharmacol. Exp. Ther. 22 (1983) 507-512.
23. + pores, Neuron 11 (1993) 503-512.
24. G.E. Kirsch, J.Z. Yeh, G.S. Oxford, Modulation of aminopyridine block of potassium currents in squid axon membranes, Biophys. J. 50 (1986) 637-644.
25. + channel, rat Kv1.4, has two potential domains that could produce rapid inactivation, J. Biol. Chem. 272 (1997) 19333-19338.
26. M. Lemeignan, J. Chanelet, N.B. Saade, Etude del'action d'un convulsivant special (la 4-aminopyridine) sur les nerfs de vertebres, Cr. Seanc. Soc. Biol. (Paris) 163 (1969) 359-365.
27. H. Lundh, O. Nilsson, I. Rosen, Treatment of Lambert-Eaton syndrome: 3,4 di-aminopyridine and pyridostigime, Neurology 34 (1984) 1324-1330.
28. + channel diversity in the mammalian central nervous system, Proc. Natl. Acad. Sci. USA 88 (1991) 3932-3936.
29. + channels, Proc. Natl. Acad. Sci. USA 88 (1994) 2931-2935.
30. + channels, Proc. Natl. Acad. Sci. USA 88 (1991) 2931-2935.
31. K.M. McEvoy, A.J. Windebank, J.R. Daube, P.A. Low, 3,4 Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome, New Engl. J. Med. 321 (1989) 1567-1571.
32. R.A. North (Ed.), Handbook of Receptors and Channels: Ligand and Voltage-Gated Ion Channels, CRC Press, Ann Arbor, MI, 1995, 349 pp.
33. K. Nunoki, K. Ishii, H. Okada, T. Yamagishi, H. Murakoshi, N. Taira, Hybrid potassium channels by tandem linkage of inactivating and non-inactivating subunits, J. Biol. Chem. 269 (1994) 24138-24142.
34. R. Perreault, M. Avioli, Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices, J. Neurophysiol. 65 (1991) 771-785.
35. + channel (Kv1.4) cloned from ferret ventricle and expressed in Xenopus oocytes, J. Physiol. 485 (1995) 59-71.
36. + channels altered by presence of β-subunit, Nature 369 (1994) 289-294.
37. S.L. Roberds, K.M. Knoth, S. Po, T.A. Blair, P.B. Bennett, R.P. Hartshorne, D.J. Snyders, M.M. Tamkun, Molecular biology of the voltage-gated potassium channels of the cardiovascular system, J. Cardiovasc. Electrophysiol. 4 (1993) 68-80.
38. + channel which maps to chromosome 1 band p21, J. Neurosci. Res. 29 (1991) 401-412.
39. K.-H. Schröter, J.P. Ruppersberg, F. Wunder, J. Rettig, M. Stocker, O. Pongs, Cloning and functional expression of a TEA-sensitive A-type potassium channel from rat brain, FEBS 278 (1991) 211-216.
40. + channel proteins in rat central neurons, Neuron 9 (1992) 271-284.
41. R.M. Sherratt, H. Bostock, T.A. Sears, Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibers, Nature 283 (1980) 570-572.
42. + channels, Biophys. J. 67 (1994) 2316-2325.
43. + channels, J. Gen. Physiol. 109 (1997) 767-778.
44. P.A. Slesinger, Y.N. Jan, L.N. Jan, The S4-S5 loop contributes to ion-selective pore of potassium channels, Neuron 11 (1993) 739-749.
45. D.F. Stefoski, F.A. Davis, M. Faut, C.L. Schauf, 4-aminopyridine improves clinical signs in multiple sclerosis, Ann. Neurol. 21 (1987) 71-77.
46. G.J. Stephens, J.C. Garratt, B. Robertson, D.G. Owen, On the mechanism of 4-aminopyridine action on the cloned mouse brain potassium channel mKv1.1, J. Physiol. 477 (1994) 187-196.
47. W. Stuhmer, J.P. Ruppersberg, K.H. Schroter, B. Sakmann, M. Stocker, K.P. Giese, A. Perschke, A. Baumann, O. Pongs, Molecular basis of functional diversity of voltage-gated potassium channels in mammalian brain, EMBO J. 8 (1989) 3235-3244.
48. E.F. Targ, J.D. Kocsis, 4-aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve, Brain 328 (1985) 358-361.
49. S. Thesleff, Aminopyridines and synaptic transmission, Neuroscience 5 (1980) 1413-1419.
50. S. Thompson, Aminopyridine block of transient potassium current, J. Gen. Physiol. 80 (1982) 1-18.
51. + channel, J. Gen. Physiol. 102 (1993) 1057-1083.
52. + channel function by deletion at the N- and C-termini, Neuron 5 (1990) 433-443.
53. P.K. Wagoner, G.S. Oxford, Aminopyridines block an inactivating potassium current having slow recovery kinetics, Biophys. J. 58 (1990) 1481-1489.
54. S.G. Waxman, Aminopyridines and the treatment of spinal cord injury, J. Neurotrauma 10 (1993) 19-24.
55. J.-A. Yao, G.-N. Tseng, Modulation of 4-AP block of a mammalian A-type K channel clone by channel gating and membrane voltage, Biophys. J. 67 (1994) 130-142.
56. J.Z. Yeh, G.S. Oxford, C.H. Wu, T. Narahashi, Dynamics of aminopyridine block of potassium channels in squid axon membrane, J. Gen. Physiol. 68 (1976) 519-535.
57. S. Yokoyama, K. Imoto, T. Kawamura, H. Higashida, N. Iwabe, T. Miyata, S. Numa, Potassium channels from NG-108-15 neuroblastoma-glioma hybrid cells: primary structure and functional expression from cDNAs, FEBS Lett. 259 (1989) 37-42.
58. W.N. Zagotta, T. Hoshi, R.W. Aldrich, Restoration of inactivation in mutants of Shaker potassium channels by peptide derived from ShB, Science 250 (1990) 568-571.